Adverum Biotechnologies reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Adverum Biotechnologies using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-04 | $-1.30 | $-1.31 | 0.76 % |
Q2 | 2024-08-12 | $-0.89 | $-1.45 | 38.6 % |
Q1 | 2024-05-09 | $-1.50 | $-1.41 | -6.38 % |
Q4 | 2024-03-18 | $-2.30 | $-3.40 | 32.4 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-04 | $1.00K | $100.00K | -99.0 % |
Q2 | 2024-08-12 | $0 | $110.00K | -100.0 % |
Q2 | 2021-08-05 | $0 | $60.00K | -100.0 % |
Q1 | 2021-05-06 | $7.50M | $60.00K | 12400.0 % |
Adverum Biotechnologies (ADVM) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on November 4, 2024 for Q3.
The Actual EPS was $-1.30, which beat the estimate of $-1.31.
The Actual Revenue was $1K, which missed the estimate of $100K.
Browse earnings estimates, EPS, and revenue on all stocks.